SCHOTT Pharma AG & Co. KGaA Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Equivalents	22.15	24.36	28.8	27.86	18.61
Short-Term Investments	-	1.53	1.49	-	-
Cash & Short-Term Investments	22.15	25.89	30.28	27.86	18.61
Cash Growth	6.00%	-14.51%	8.70%	49.73%	-
Accounts Receivable	255.6	223.7	199.05	150.94	130.76
Other Receivables	2.09	27.25	27.61	15.76	12.71
Receivables	380.46	287.23	389.23	187.13	153.52
Inventory	145.47	138.94	128.94	83.52	63.22
Prepaid Expenses	-	3.13	2.94	1.88	1.08
Other Current Assets	37.87	13.15	3.13	1.77	2.56
Total Current Assets	585.95	468.34	554.52	302.16	238.98
Property, Plant & Equipment	679.74	637.81	517.21	334.14	267
Long-Term Investments	84.86	79.06	79.82	62.26	49.46
Goodwill	-	29.49	30.95	29.33	28.39
Other Intangible Assets	30.56	1.45	1.92	1.72	2.61
Long-Term Deferred Tax Assets	17.59	14.83	11.75	10.11	9.48
Other Long-Term Assets	0.31	0.84	0.33	0.18	0.08
Total Assets	1,399	1,232	1,197	739.89	596.02
Accounts Payable	91.05	90.64	99.6	63.38	61.55
Accrued Expenses	52.97	52.86	46.58	39	30.95
Short-Term Debt	188.4	137.47	120.57	96.98	86.95
Current Portion of Leases	-	3.14	3.38	1.39	0.85
Current Income Taxes Payable	24.97	20.4	12.65	16.3	14.48
Current Unearned Revenue	23.7	20.5	14.76	8.84	0.82
Other Current Liabilities	34.53	26.14	25.49	18.32	14.26
Total Current Liabilities	415.61	351.15	323.02	244.21	209.86
Long-Term Leases	81.09	69.19	71.43	2.21	3.38
Long-Term Unearned Revenue	78.63	66.14	39.95	19.85	6.91
Long-Term Deferred Tax Liabilities	19.78	24.82	20.7	11.75	8.07
Other Long-Term Liabilities	8.4	9.57	17.73	8.3	7.98
Total Liabilities	629.73	539.65	487.46	320.48	280.36
Common Stock	150.62	150.62	-	-	-
Comprehensive Income & Other	616.95	539.82	707.28	417.96	314.52
Total Common Equity	767.57	690.43	707.28	417.96	314.52
Minority Interest	1.74	1.75	1.77	1.46	1.14
Shareholders' Equity	769.31	692.18	709.04	419.42	315.66
Total Liabilities & Equity	1,399	1,232	1,197	739.89	596.02
Total Debt	269.49	209.81	195.38	100.58	91.18
Net Cash (Debt)	-247.34	-183.92	-165.09	-72.72	-72.58
Net Cash Per Share	-1.64	-1.22	-1.10	-0.48	-0.48
Filing Date Shares Outstanding	148.88	150.61	150.61	150.61	150.61
Total Common Shares Outstanding	148.88	150.61	150.61	150.61	150.61
Working Capital	170.34	117.19	231.5	57.95	29.12
Book Value Per Share	5.16	4.58	4.70	2.78	2.09
Tangible Book Value	737.01	659.49	674.41	386.91	283.52
Tangible Book Value Per Share	4.95	4.38	4.48	2.57	1.88
Land	-	260.95	240.49	143.56	133.19
Machinery	-	615.67	565.37	443.39	397.85
Construction In Progress	-	250.62	173.47	122.12	86.35

Source: S&P Capital IQ. Standard template. Financial Sources.